← Leaderboards
Michelle Krogsgaard
New York University School Of Medicine
$10,631,626
Attributed
$15,149,201
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,149,201 · 10
By mechanism
R01$8,337,285 · 4
U01$4,618,936 · 2
P50$1,692,996 · 1
S10$359,704 · 1
P30$140,280 · 2
Top collaborators
- Cheng Zhu17 shared
- Nathaniel J. Traaseth1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Iman Osman$8,470,073
- Aswin Natarajan$431,866
- Mark Reid Philips$38,261,818
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteResponseAntigensT-Cell ReceptorT-Cell ActivationSignal TransductionMalignant NeoplasmsTumorMelanomaReceptor SignalingMouse ModelMolecularBaseDesignCellsImmuneAffinityExperimental StudyEventLigandsPeptidesCd8b1 GeneBindingImmune Response
Grant awards (43)
Optimizing TCR-CD3 signaling for immunotherapy of cancer$634,208
R01 · FY2025 · CA · contact PI
Tumor Immunology (TIM) Research Program$53,883
P30 · FY2025 · CA · contact PI
Optimizing TCR-CD3 signaling for immunotherapy of cancer$652,880
R01 · FY2024 · CA · contact PI
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade$610,178
R01 · FY2024 · CA · contact PI
Project 3$343,215
P50 · FY2024 · CA · contact PI
Tumor Immunology (TIM) Research Program$53,881
P30 · FY2024 · CA · contact PI
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade$557,231
R01 · FY2023 · CA · contact PI
Project 3$246,163
P50 · FY2023 · CA · contact PI
Tumor Immunology (TIM) Research Program$16,386
P30 · FY2023 · CA · contact PI
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade$629,441
R01 · FY2022 · CA · contact PI
Project 3$283,170
P50 · FY2022 · CA · contact PI
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade$72,215
R01 · FY2022 · CA · contact PI
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade$670,428
R01 · FY2021 · CA · contact PI
Mechanisms of impaired T-cell mechanosensing of melanoma antigens$643,620
U01 · FY2021 · CA
Mechanisms of initiation of T-cell signaling by the TCR-CD3 complex$468,382
R01 · FY2021 · GM · contact PI
Project 3$289,491
P50 · FY2021 · CA · contact PI
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade$57,464
R01 · FY2021 · CA · contact PI
Mechanisms of impaired T-cell mechanosensing of melanoma antigens$946,295
U01 · FY2020 · CA
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade$704,403
R01 · FY2020 · CA · contact PI
Mechanisms of initiation of T-cell signaling by the TCR-CD3 complex$470,741
R01 · FY2020 · GM · contact PI
Project 3$268,195
P50 · FY2020 · CA · contact PI
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade$169,500
R01 · FY2020 · CA · contact PI
Mechanisms of initiation of T-cell signaling by the TCR-CD3 complex$90,000
R01 · FY2020 · GM · contact PI
Mechanisms of initiation of T-cell signaling by the TCR-CD3 complex$24,849
R01 · FY2020 · GM · contact PI
Mechanisms of impaired T-cell mechanosensing of melanoma antigens$625,074
U01 · FY2019 · CA
Mechanisms of initiation of T-cell signaling by the TCR-CD3 complex$473,031
R01 · FY2019 · GM · contact PI
Project 3$262,762
P50 · FY2019 · CA · contact PI
Mechanisms of impaired T-cell mechanosensing of melanoma antigens$53,699
U01 · FY2019 · CA
Tumor Immunology (TIM) Research Program$16,130
P30 · FY2019 · CA · contact PI
Mechanisms of impaired T-cell mechanosensing of melanoma antigens$811,389
U01 · FY2018 · CA
Mechanisms of initiation of T-cell signaling by the TCR-CD3 complex$531,728
R01 · FY2018 · GM · contact PI
Divesity Supplement Mechanisms of impaired T-cell mechanosensing of melanoma Antigens$57,138
U01 · FY2018 · CA
Mechanisms of impaired T-cell mechanosensing of melanoma antigens$780,284
U01 · FY2017 · CA
Acquisition of a Cryoprobe for a 600 MHz NMR Spectrometer$359,704
S10 · FY2014 · OD
Visualizing ligand-induced signal propagation in the TCR-signaling complex$36,780
R01 · FY2014 · GM · contact PI
Visualizing ligand-induced signal propagation in the TCR-signaling complex$332,254
R01 · FY2011 · GM · contact PI
Biophysical analysis of T-cell discrimination among classes of self-ligands$350,675
U01 · FY2010 · CA · contact PI
Visualizing ligand-induced signal propagation in the TCR-signaling complex$342,462
R01 · FY2010 · GM · contact PI
Visualizing ligand-induced signal propagation in the TCR-signaling complex$75,000
R01 · FY2010 · GM · contact PI
Visualizing ligand-induced signal propagation in the TCR-signaling complex$56,193
R01 · FY2010 · GM · contact PI
Biophysical analysis of T-cell discrimination among classes of self-ligands$350,762
U01 · FY2009 · CA · contact PI
Visualizing ligand-induced signal propagation in the TCR-signaling complex$339,000
R01 · FY2009 · GM · contact PI
Visualizing ligand-induced signal propagation in the TCR-signaling complex$338,917
R01 · FY2008 · GM · contact PI